Pfizer Inc.

Dow slips 200 points as investors brace for more September volatility

Read more

S&P 500 rises, Pfizer’s vaccine shows promise, Fed minutes analysis

Read more

CDC endorses third Pfizer doses for high-risk adults

Read more

CDC director defends controversial call on Pfizer’s Covid boosters

Read more

Dr. Scott Gottlieb weighs in on Pfizer’s Covid booster approval process

Read more

Whether COVID-19 boosters get approved or not, Pfizer and Moderna have

Read more

J&J Covid vaccine booster shot is 94% effective when given at two months

Read more

Here’s why the FDA may approve a Covid-19 vaccine before the November

Read more

Fauci defends FDA panel decision to reject third doses for all Americans

Read more

‘Shoulda Got the Shot’: New PSAs employ real people rather than science and

Read more